If Viraleze 7 day treatment is competing with Paxlovid - who wins, page-7

‘I often think how easy it is for competitors to put lots of challenges into forums’ ~@ Maz2024

The same can be said of company stooges and significant shareholders, trying to do the opposite in public forums.

And by that I mean whitewashing the missteps and failures, continuing the company spin, talking about rocket ship scenarios and pumping extraordinary share price predictions.

Plenty of that has been going on here for years. Fortunately, when the tide eventually goes out, we find out who’s swimming naked.

At 12.5 cents it’s looking like the Starpharma pantomime is almost over. Need some good news of substance real soon.